0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Kits > IL-17A > CEA-C092

ClinMax™ Human IL-17A / CTLA8 ELISA Kit

For research use only.

Order Now

    Product Details
    ClinMax™ Human IL-17A / CTLA8 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human IL-17A / CTLA8 that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:
    1. Standards to calibrate with NIBSC/WHO standards for comparable results.
    2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.
  • Application

    The kit is developed for quantitative detection of natural and recombinant human IL-17A / CTLA8 in serum, plasma and cell culture supernatants.

    It is for research use only.

  • Workflow
     IL-17A Workflow
    Key Features
    AnalyteIL-17A/CTLA8
    Assay TypeSandwich-ELISA
    ReactivityHuman
    Sensitivity<6pg/mL
    Range31.25 pg/mL-2000 pg/ml
    Assay Time2hr
    Sample TypeCell Culture Supernatants, Plasma, Serum.
    Sample volume50 μL
    Format96-wells plate breakable into 12 x 8 wells strips

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Storage
    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Typical Data Please refer to DS document for the assay protocol.
 IL-17A TYPICAL DATA

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of IL-17A is less than 6 pg/mL.

Validation
Intra-Assay Statistics

Ten replicates of each of 4 samples containing different IL-17A concentrations were tested in one assay. Acceptable criteria: CV<10%.

 IL-17A INTRA-ASSAY STATISTICS
Inter-Assay Statistics

Five samples containing different concentrations of IL-17A were tested in independent assays. Acceptable criteria: CV<15%.

 IL-17A INTER-ASSAY STATISTICS
Recovery

Recombinant IL-17A was spiked into 3 human serum samples, and then analyzed. The average recovery of IL-17A for serum samples is 85.37%.

 IL-17A RECOVERY
Materials Provided
IDComponentsSize
CEA092-C01Pre-coated Anti-IL-17A Antibody Microplate1 plate
CEA092-C02Human IL-17A Standard20μg ×2
CEA092-C03Biotin-Anti-IL-17A Antibody Con. Solution300 μL
CEA092-C04Biotin-Antibody Dilution Buffer8 mL
CEA092-C05Streptavidin-HRP Con. Solution500 uL
CEA092-C06Streptavidin-HRP Dilution Buffer15 mL
CEA092-C0720× Washing Buffer50 mL
CEA092-C08Sample Dilution Buffer15 mL ×2
CEA092-C09Substrate Solution12 mL
CEA092-C10Stop Solution6 mL
  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €500.00

Price(EUR) :


Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:3 Details
  • Number of Drugs in Clinical Trials:29 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message